Open AccessINTENSE PULSED LIGHT (IPL) TREATMENT FOR DUPILUMAB INDUCED OCULAR SURFACE DISEASE (DIOSD)
Author(s) -
Sathi Maiti,
Laura M. Periman,
Natasha Balani
Publication year - 2022
Publication title -
journal of dry eye and ocular surface disease
Language(s) - English
Resource type - Journals
ISSN - 2561-9195
DOI - 10.22374/jded.v5i1.40
Subject(s) - dupilumab , medicine , intense pulsed light , adjunct , dermatology , atopic dermatitis , philosophy , linguistics
PurposeTo report a case of dupilumab induced ocular surface disease (DIOSD) managed with intense pulsed light (IPL) as an effective adjunct therapy to topical steroids and topical immunomodulator lifitegrast.MethodsDiscussion of a patient’s case with accompanying anterior segment and meibography photos with diagnosed DIOSD for which adjunct therapy with IPL was an effective treatment after limited relief from and difficulty with adherence to traditional treatment with topical steroids and lifitegrast ophthalmic solutions. ConclusionThis case demonstrates the complexity of management required to treat patients with DIOSD and its chronic nature. IPL as a nonpharmaceutical adjunct therapy to topical steroids and immunomodulators in the treatment of DIOSD showed improved signs and symptoms of DIOSD.